Anti-fungal activity of broxyquinoline and brobenzoxaldine.
D000935:Antifungal Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001565:Benzoates / Q000009:adverse effects / Q000627:therapeutic use*; D001966:Bromine / Q000009:adverse effects / Q000627:therapeutic use*; D002177:Candidiasis / Q000517:prevention & control*; D004338:Drug Combinations; D004357:Drug Synergism; D006801:Humans; D011804:Quinolines / Q000009:adverse effects / Q000627:therapeutic use*; D013752:Tetracycline / Q000627:therapeutic use
D000935:Antifungal Agents; D001565:Benzoates; D004338:Drug Combinations; D011804:Quinolines; D013752:Tetracycline; D001966:Bromine